Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?

J. Levitsky; R. N. Formica

doi:10.1111/ajt.14478

Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?

J. Levitsky^*, R. N. Formica

^*Corresponding author for this work

Medicine, Hepatology Division

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	2988
Number of pages	1
Journal	American Journal of Transplantation
Volume	17
Issue number	11
DOIs	https://doi.org/10.1111/ajt.14478
State	Published - Nov 2017

Keywords

clinical decision-making
clinical research/practice
infection and infectious agents - viral: hepatitis C
liver transplantation/hepatology

ASJC Scopus subject areas

Immunology and Allergy
Transplantation
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ajt.14478

Cite this

@article{e1867426216d41a8954536d5327aadfe,

title = "Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?",

keywords = "clinical decision-making, clinical research/practice, infection and infectious agents - viral: hepatitis C, liver transplantation/hepatology",

author = "J. Levitsky and Formica, {R. N.}",

year = "2017",

month = nov,

doi = "10.1111/ajt.14478",

language = "English (US)",

volume = "17",

pages = "2988",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Elsevier B.V.",

number = "11",

}

TY - JOUR

T1 - Response to

T2 - HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?

AU - Levitsky, J.

AU - Formica, R. N.

PY - 2017/11

Y1 - 2017/11

KW - clinical decision-making

KW - clinical research/practice

KW - infection and infectious agents - viral: hepatitis C

KW - liver transplantation/hepatology

UR - http://www.scopus.com/inward/record.url?scp=85030238300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030238300&partnerID=8YFLogxK

U2 - 10.1111/ajt.14478

DO - 10.1111/ajt.14478

M3 - Letter

C2 - 28858416

AN - SCOPUS:85030238300

SN - 1600-6135

VL - 17

SP - 2988

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 11

ER -

Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this